Cleared Traditional

K201867 - Homechoice Claria APD System

K201867 is the FDA 510(k) clearance for Homechoice Claria APD System by Baxter Healthcare Corporation. It is a Class 2 Gastroenterology & Urology device (product code FKX) cleared through the Traditional 510(k) pathway after a 135-day FDA review.

K201867 · Baxter Healthcare Corporation · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2020
Decision
135d
Days
Class 2
Risk

K201867 is an FDA 510(k) clearance for the Homechoice Claria APD System, Sharesource Connectivity Platform for Use with .... Classified as System, Peritoneal, Automatic Delivery (product code FKX), Class II - Special Controls.

Submitted by Baxter Healthcare Corporation (Round Lake, US). The FDA issued a Cleared decision on November 19, 2020 after a review of 135 days - within the typical 510(k) review window.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.5630 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.

View all Baxter Healthcare Corporation devices

Submission Details

510(k) Number K201867 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 07, 2020
Decision Date November 19, 2020
Days to Decision 135 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
5d slower than avg
Panel avg: 130d · This submission: 135d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FKX System, Peritoneal, Automatic Delivery
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.5630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - FKX System, Peritoneal, Automatic Delivery

All 45
Devices cleared under the same product code (FKX) and FDA review panel - the closest regulatory comparables to K201867.
Fresenius Liberty Select Cycler
K222318 · Fresenius Medical Care Renal Therapies Group, LLC · Oct 2022
Lilliput APD System
K212522 · Fresenius Medical Care Renal Therapies Group, LLC · Apr 2022
CloudCath Peritoneal Dialysis Drain Set Monitoring System
K212658 · Cloudcath · Feb 2022
Fresenius Liberty Select Cycler
K181108 · Fresenius Medical Care Renal Therapies Group, LLC · May 2018
Liberty Cycler Set
K173718 · Fresenius Medical Care Renal Therapies Group, LLC · May 2018
Fresenius Liberty Select Cycler
K171652 · Fresenius Medical Care Renal Therapies Group, LLC · Sep 2017